Testing for HIV in newborns and starting treatment with Dolutegravir early
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants
This study is working to make sure that babies in Botswana get tested for HIV right after birth and start on a new, better medicine called Dolutegravir quickly, to help keep them healthy and reduce the risk of serious illness.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard School of Public Health NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10914860 on NIH RePORTER |
What this research studies
This research focuses on improving the diagnosis and treatment of HIV in infants, particularly in Botswana. It aims to implement point-of-care HIV testing at birth and initiate treatment with Dolutegravir, a newer and more effective medication, as soon as possible. The study addresses the urgent need for timely diagnosis and effective treatment to reduce the high mortality rates associated with HIV in infants. By collaborating with local health authorities, the research seeks to integrate these practices into national health programs.
Who could benefit from this research
Good fit: Ideal candidates for this research are newborns diagnosed with HIV within the first few weeks of life.
Not a fit: Patients who are older than one month or those who do not have HIV will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce HIV-related deaths in infants by ensuring they receive timely and effective treatment.
How similar studies have performed: Previous research has shown promise in using Dolutegravir for treating HIV in infants, but this specific implementation approach is novel.
Where this research is happening
Boston, United States
- Harvard School of Public Health — Boston, United States (Active)
Researchers
- Principal investigator: Shapiro, Roger L — Harvard School of Public Health
- Study coordinator: Shapiro, Roger L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.